ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6,995 | $7,382 | $6,259 | $3,432 |
| - Cash | $328 | $157 | $89 | $50 |
| + Debt | $771 | $60 | $47 | $25 |
| Enterprise Value | $7,437 | $7,285 | $6,217 | $3,406 |
| Revenue | $730 | $490 | $237 | $68 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Gross Profit | $635 | $425 | $196 | $47 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| EBITDA | $191 | $128 | -$1 | -$63 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |
| Net Income | $147 | $216 | -$9 | -$66 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| % Growth | -32.5% | 2,292.3% | 86.9% | – |
| Operating Cash Flow | $196 | $118 | $15 | -$71 |
| Capital Expenditures | -$31 | -$25 | -$12 | -$12 |
| Free Cash Flow | $165 | $93 | $3 | -$83 |